阵发性睡眠性血红蛋白尿症及再生障碍性贫血患者WT1基因启动子区甲基化状态的研究
被引量:2
摘要
阵发性睡眠性血红蛋白尿症(PNH)患者常有反复的血红蛋白尿和持久的贫血,究竟是什么原因导致PNH克隆优势造血呢?研究表明,WT1基因启动子区DNA甲基化状态是使PNH克隆大量扩增的机制之一.我们采用甲基化特异性PCR(MSP)法研究PNH患者、再生障碍性贫血(AA)患者WTI基因启动子区域DNA甲基化模式的改变,初步探讨表观遗传学调控方式在PNH和AA发病机制中的作用.
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2010年第4期273-274,共2页
Chinese Journal of Hematology
参考文献3
-
1Shichishima T,Okamoto M,Ikeda K,et al.HLA class II haplo-type and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria.Blood,2002,100;22-28.
-
2赵晔,陈子兴,胡绍燕,岑建农,顾伟英.造血系统肿瘤WT1基因启动子区域DNA甲基化及其调控的研究[J].中华血液学杂志,2005,26(9):517-520. 被引量:3
-
3Loeb DM,Evron E,Patel CB,et al.Wilms' tumor suppressor gene(WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.Cancer Res,2001,61:921-925.
二级参考文献16
-
1Merl A, Herman JG, Mao L, et al. 5'-CpG island methylation is associated with transcriptional silencing of the tumor suppressor P16/CDKN2/MTS in human cancers. Nat Med, 1995,1: 686-692.
-
2Cody DT, Huang Y, Dargy CJ, et al. Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral kerarinocytes. Oral Oncol, 1999, 35: 516-522.
-
3James GH, Jeremy RG, Sanna M, et al. Methylation-specific PCR:a novel PCR for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996, 93: 9821-9826.
-
4David ML, Ella E, Chirag BP, et al. Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumorspecific promoter methylation. Cancer Res, 2001,61: 921-925.
-
5Yuji S, Tetsuji N, Hisaya N, et al. Significant reduction of WTIgene expression, possibly due to epigenetic alteration in Wilms'Tumor. J Biochem, 2003, 133: 303-308.
-
6Wang ZY, Qiu QQ, Deuel TF. The Wilms' tumor gene product WT1activates of suppresses transcription through separate functional domains. J Biol Chem, 1993, 268: 9172-9175.
-
7Reddy JC, Hosono S, Licht JD. The transcriptional effect of WT1 is modulated by choice of expression vector. J Biol Chem, 1995, 270:29976-29982.
-
8Reddy JC, Licht JD. The WT1 Wilms' tumor suppressor gene: how much do we really know? Biochem Biophys Acta, 1996,1287: 1-28.
-
9Miwa H, Beran M, Saunder GF. Expression of the Wilms' tumor gene ( WT1 ) inhuman leukemias. Leukemia, 1992, 6: 405-409.
-
10Inoue K, Sugiyama H, Ogama H, et al. WT1 as a new prognostic factor and new marker for the detection of minimal residual disease in acute leukemia. Blood, 1994, 84: 3071-3079.
同被引文献28
-
1Araten DJ, Nafa K, Pakdeesuwan K, et al. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals [J]. Proc Natl Acad Sci U S A, 1999, 96(9):5209-5214.
-
2Keller P, Payne JL, Tremml G, et al. FES-Cre targets phosphati- dylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow [J]. J Exp Meal, 2001, 194(5): 581-589.
-
3Ikeda K, Shichishima T, Yasukawa M, et al. The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immu- nologic selection of a paroxysmal noctumal hemoglobinttfia clone [ J ]. Exp Hematol, 2007, 35 ( 4 ) :618-626.
-
4Sugiyama H. WT1 (Wilms' tumor gene 1 ): biology and cancer immunotherapy[ J]. Jpn J Clin Oncol, 2010, 40 (5) :377-387.
-
5Shichishima T, Okamoto M, Ikeda K, et al. HLA class II haplo- type and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria [ J ]. Blood, 2002, 100 ( 1 ): 22-28.
-
6Parker CJ. The pathophysiology of paroxysmal noctumal hemo- globinuria[ J]. Exp Hematol, 2007, 35(4):523-533.
-
7Hu R, Mukhina GL, Piantadosi S, et al. PIG-A mutations in nor- mal hematopoiesis[J]. Blood, 2005, 105( 1 ):3848-3854.
-
8Karadimitris A, Luzzatto L. The cellular pathogenesis of parox- ysmal nocturnal haemoglobinuria [J]. Leukemia, 2001, 15 (8): 1148-1152.
-
9Brodsky RA, Vala MS, Barber JP, et al. Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemo- globinuria [ J ]. Proc Natl Acad Sci U S A, 1997, 94 (16) :8756- 8760.
-
10DACIE JV, LEWIS SM. Paroxysmal nocturnal haemoglobin- uria: variation in clinical severity and association with bone-mar- row hypoplasia[J]. Br J Haematol, 1961, 7:442-457.
引证文献2
-
1张媛媛,付蓉,王一浩,李丽娟,刘惠,刘春燕,张田,丁少雪,李丽燕,阮二宝,瞿文,王化泉,王晓明,王国锦,吴玉红,宋嘉,刘鸿,邢莉民,关晶,邵宗鸿.WT1基因异常表达在阵发性睡眠性血红蛋白尿症发病机制中的作用[J].中华血液学杂志,2014,35(7):596-600. 被引量:2
-
2韦中玲,戴艳,黄来全,蒋艺枝,黄东平.异基因造血干细胞移植治疗EVI1阳性阵发性睡眠性再生障碍性贫血-血红蛋白尿综合征一例临床分析[J].中国全科医学,2016,19(30):3765-3768. 被引量:2
二级引证文献4
-
1韦中玲,戴艳,黄来全,蒋艺枝,黄东平.异基因造血干细胞移植治疗EVI1阳性阵发性睡眠性再生障碍性贫血-血红蛋白尿综合征一例临床分析[J].中国全科医学,2016,19(30):3765-3768. 被引量:2
-
2刘希民.造血干细胞移植治疗阵发性睡眠性血红蛋白尿2例及文献复习[J].中国实用医药,2017,12(25):156-157. 被引量:1
-
3杨郁青,肖锋.再生障碍性贫血采用祛铁治疗对输血相关性铁过载的影响[J].现代诊断与治疗,2017,28(21):3931-3933. 被引量:2
-
4刘珍珍,卢润青,谢新生,姜中兴,何飞,樊冀鑫,赵海秋,郭荣.单倍体造血干细胞移植治疗伴阵发性睡眠性血红蛋白尿克隆的重型再生障碍性贫血的临床效果[J].河南医学研究,2021,30(19):3463-3467. 被引量:1
-
1靳松,沈干,胡世莲,马礼坤,吴蕾,陈尹,徐婷娟.雌激素受体α启动子区甲基化与冠状动脉粥样硬化的关系[J].中国老年学杂志,2011,31(7):1102-1104. 被引量:5
-
2张媛媛,付蓉,王一浩,李丽娟,刘惠,刘春燕,张田,丁少雪,李丽燕,阮二宝,瞿文,王化泉,王晓明,王国锦,吴玉红,宋嘉,刘鸿,邢莉民,关晶,邵宗鸿.WT1基因异常表达在阵发性睡眠性血红蛋白尿症发病机制中的作用[J].中华血液学杂志,2014,35(7):596-600. 被引量:2
-
3李永志,李维佳,黄颖.WT1基因与急性白血病研究新进展[J].医学综述,2010,16(9):1336-1339. 被引量:1
-
4刘力,姜文瑞,刘雄涛,王洪涛,李军,俞翔,舒青,郑强荪.动脉粥样硬化与12/15-LOX基因启动子区甲基化状态的关系[J].心脏杂志,2009,21(2):183-185. 被引量:1
-
5王玲.WT1基因与造血系统疾病[J].国外医学(输血及血液学分册),2000,23(4):245-247.
-
6曾春梅,冉学红,赵莎莎,张曦.WT1基因在急性白血病患者中的表达及其临床意义[J].现代医药卫生,2011,27(7):974-976. 被引量:5
-
7赵晓丽,王小钦,李爽,李念夷,马燕,林果为.骨髓增生异常综合征CpG岛甲基化模式的建立及其诊断价值研究[J].中华血液学杂志,2014,35(10):944-948. 被引量:3
-
8李安生,李遇梅,杨爱珍,姚煦,陈志强.系统性红斑狼疮患者血浆和血细胞DNA中p16基因启动子区甲基化现象和意义[J].中国医学科学院学报,2006,28(5):675-681. 被引量:1
-
9赵晔,陈子兴,胡绍燕,岑建农.白血病细胞系中WT1基因启动子区域DNA甲基化的研究[J].苏州大学学报(医学版),2005,25(2):175-177. 被引量:1
-
10遗传与染色体疾病[J].中国医学文摘(儿科学),2008,27(6):513-514.